Chemed (CHE)
(Real Time Quote from BATS)
$562.80 USD
-2.72 (-0.48%)
Updated May 20, 2024 01:36 PM ET
4-Sell of 5 4
C Value B Growth B Momentum C VGM
Price, Consensus and EPS Surprise
CHE 562.80 -2.72(-0.48%)
Will CHE be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for CHE based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CHE
Should iShares MSCI USA Small-Cap Min Vol Factor ETF (SMMV) Be on Your Investing Radar?
EHC or CHE: Which Is the Better Value Stock Right Now?
CHE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Chemed (CHE) Lags Q1 Earnings Estimates, Reaffirms 2024 View
Chemed (CHE) Q1 Earnings Miss Estimates
Here's Why You Should Retain Chemed (CHE) Stock for Now
Other News for CHE
Chemed: Growth Does Not Justify The Current Stock Price
Chemed CEO McNamara sells 4,000 common shares
Chemed Corp (CHE) CEO Kevin Mcnamara Sells 4,000 Shares
Analysts Offer Insights on Healthcare Companies: Chemed (CHE), Acadia Healthcare (ACHC) and Taysha Gene Therapies (TSHA)
Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2024